Loading
Latest filing published 26 Sept 2013 for KV PHARMACEUTICAL CO /DE/.
No signal scores available.
Gregory Smith Bentley discloses dealings in KV Pharmaceutical Co /DE/ to SEC (Form 4). Over a trading history stretching from 10 June 2010 to 16 September 2013, the count stands at 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 26 September 2013: a transaction, in KV Pharmaceutical Co /DE/. The median gap between a trade and its publication by SEC (Form 4) is 10 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations